» Articles » PMID: 35884904

Molecular Mechanisms of Autophagy in Cancer Development, Progression, and Therapy

Abstract

Autophagy is an evolutionarily conserved and tightly regulated process that plays an important role in maintaining cellular homeostasis. It involves regulation of various genes that function to degrade unnecessary or dysfunctional cellular components, and to recycle metabolic substrates. Autophagy is modulated by many factors, such as nutritional status, energy level, hypoxic conditions, endoplasmic reticulum stress, hormonal stimulation and drugs, and these factors can regulate autophagy both upstream and downstream of the pathway. In cancer, autophagy acts as a double-edged sword depending on the tissue type and stage of tumorigenesis. On the one hand, autophagy promotes tumor progression in advanced stages by stimulating tumor growth. On the other hand, autophagy inhibits tumor development in the early stages by enhancing its tumor suppressor activity. Moreover, autophagy drives resistance to anticancer therapy, even though in some tumor types, its activation induces lethal effects on cancer cells. In this review, we summarize the biological mechanisms of autophagy and its dual role in cancer. In addition, we report the current understanding of autophagy in some cancer types with markedly high incidence and/or lethality, and the existing therapeutic strategies targeting autophagy for the treatment of cancer.

Citing Articles

The RNA-binding protein ELAVL1 promotes Beclin1-mediated cellular autophagy and thus endometrial cancer development by affecting LncRNA-neat stability.

Luo Y, Zhong X, Sun X, Fan J Cancer Biol Ther. 2025; 26(1):2469927.

PMID: 40018990 PMC: 11875488. DOI: 10.1080/15384047.2025.2469927.


Curcumin enhances ATG3-dependent autophagy and inhibits metastasis in cervical carcinoma.

Zheng F, Lu J, Wang C, Yu H, Fu Y, Ma D Cell Div. 2024; 19(1):33.

PMID: 39609925 PMC: 11606299. DOI: 10.1186/s13008-024-00138-6.


Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapy.

Hashemi M, Khosroshahi E, Tanha M, Khoushab S, Bizhanpour A, Azizi F Heliyon. 2024; 10(18):e37376.

PMID: 39309904 PMC: 11415696. DOI: 10.1016/j.heliyon.2024.e37376.


Epithelial-mesenchymal plasticity in cancer: signaling pathways and therapeutic targets.

Wang X, Xue X, Pang M, Yu L, Qian J, Li X MedComm (2020). 2024; 5(8):e659.

PMID: 39092293 PMC: 11292400. DOI: 10.1002/mco2.659.


Exploring Importance and Regulation of Autophagy in Cancer Stem Cells and Stem Cell-Based Therapies.

Rahman M, Apu E, Rakib-Uz-Zaman S, Chakraborti S, Bhajan S, Taleb S Cells. 2024; 13(11.

PMID: 38891090 PMC: 11171866. DOI: 10.3390/cells13110958.


References
1.
Renault V, Thekkat P, Hoang K, White J, Brady C, Broz D . The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor. Oncogene. 2011; 30(29):3207-21. PMC: 3136551. DOI: 10.1038/onc.2011.35. View

2.
Barbone D, Follo C, Echeverry N, Gerbaudo V, Klabatsa A, Bueno R . Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models. PLoS One. 2015; 10(8):e0134825. PMC: 4540424. DOI: 10.1371/journal.pone.0134825. View

3.
Paoli P, Giannoni E, Chiarugi P . Anoikis molecular pathways and its role in cancer progression. Biochim Biophys Acta. 2013; 1833(12):3481-3498. DOI: 10.1016/j.bbamcr.2013.06.026. View

4.
Seok J, Hong E, Yang G, Lee H, Kim S, Liu K . Oxidized Phospholipids in Tumor Microenvironment Stimulate Tumor Metastasis via Regulation of Autophagy. Cells. 2021; 10(3). PMC: 8001732. DOI: 10.3390/cells10030558. View

5.
Wang C, Lin S, Huang Y, Hsieh C, Chang H, Chen H . Paired-like homeodomain 2B contributes to tumour progression and anti-autophagy in human lung cancer. Am J Cancer Res. 2021; 11(10):4900-4918. PMC: 8569349. View